Wong Chris Ho-Ming, Ko Ivan Ching-Ho, Leung David Ka-Wai, Liu Kang, Zhao Hongda, Alvarez-Maestro Mario, Pes Maria Del Pilar Laguna, de la Rosette Jean, Teoh Jeremy Yuen-Chun
S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Department of Urology, Hospital Universitario La Paz, 28046 Madrid, Spain.
Cancers (Basel). 2024 Jul 28;16(15):2683. doi: 10.3390/cancers16152683.
(1) Introduction: Diagnostic ureteroscopy (URS) is an important component in the workup of upper tract urothelial carcinoma (UTUC). Whether URS was associated with increased recurrence in the bladder was not fully concluded. The current study aimed to evaluate the implication of URS on the incidences of intravesical recurrence following radical nephroureterectomy (RNU) in non-metastatic UTUC patients without prior history of bladder cancer via multi-institutional data. (2) Patients and Methods: Data were obtained from the Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) registry, a prospective, multicentre database. Patients with non-metastatic UTUC treated with RNU were divided into two groups: those undergoing upfront RNU and those having diagnostic URS prior to RNU. Intravesical recurrence-free survival (IVRS) was the primary endpoint, evaluated through Kaplan-Meier analysis and multivariate Cox regression. Cases with adequate follow-up data were included. (3) Results: The analysis included 269 patients. Of these, 137 (50.9%) received upfront RNU and 132 (49.1%) received pre-RNU URS. The URS group exhibited an inferior 24-month IVRS compared to the upfront RNU group (HR = 1.705, 95% CI = 1.082-2.688; = 0.020). Multivariate analysis confirmed URS as the only significant predictor of IVR ( = 0.019). Ureteric access sheath usage, flexible ureteroscopy, ureteric biopsy, retrograde contrast studies, and the duration of URS did not significantly affect IVRS. (4) Conclusions: Diagnostic URS prior to RNU was found to be associated with an increased risk of IVR in patients with UTUC. The risk was not significantly influenced by auxiliary procedures during URS. Physicians were advised to meticulously evaluate the necessity of diagnostic URS.
(1) 引言:诊断性输尿管镜检查(URS)是上尿路尿路上皮癌(UTUC)检查工作的重要组成部分。URS是否与膀胱复发增加相关尚未完全明确。本研究旨在通过多机构数据评估URS对无膀胱癌既往史的非转移性UTUC患者根治性肾输尿管切除术(RNU)后膀胱内复发发生率的影响。(2) 患者与方法:数据来自泌尿外科内镜学会上尿路尿路上皮癌临床研究办公室(CROES-UTUC)登记处,这是一个前瞻性多中心数据库。接受RNU治疗的非转移性UTUC患者分为两组:接受直接RNU的患者和在RNU之前进行诊断性URS的患者。膀胱内无复发生存期(IVRS)是主要终点,通过Kaplan-Meier分析和多变量Cox回归进行评估。纳入有充分随访数据的病例。(3) 结果:分析包括269例患者。其中,137例(50.9%)接受直接RNU,132例(49.1%)接受RNU前的URS。与直接RNU组相比,URS组的24个月IVRS较差(HR = 1.705,95% CI = 1.082 - 2.688;P = 0.020)。多变量分析证实URS是IVR的唯一显著预测因素(P = 0.019)。输尿管通路鞘的使用、软性输尿管镜检查、输尿管活检、逆行造影研究以及URS的持续时间对IVRS没有显著影响。(4) 结论:发现在RNU之前进行诊断性URS与UTUC患者IVR风险增加相关。该风险未受到URS期间辅助操作的显著影响。建议医生仔细评估诊断性URS的必要性。